Prevention of Cyclophosphamide-induced Accelerated Diabetes in the NOD Mouse by Nicotinamide or a Soy Protein-based Infant Formula
2001

Preventing Diabetes in Mice with Nicotinamide and Soy Protein

Sample size: 55 publication Evidence: high

Author Information

Author(s): S. REDDY, M. KARANAM, E. ROBINSON

Primary Institution: University of Auckland

Hypothesis

Can oral nicotinamide or a soy protein-based infant formula prevent cyclophosphamide-induced diabetes in NOD mice?

Conclusion

Oral nicotinamide or Prosobee, either alone or together, prevents cyclophosphamide-induced diabetes in NOD mice.

Supporting Evidence

  • NOD mice given cyclophosphamide developed diabetes at a rate of 63%, while those given nicotinamide or Prosobee did not develop diabetes.
  • Insulitis scores were significantly lower in mice treated with nicotinamide or Prosobee compared to those on a standard diet.
  • Oral nicotinamide and Prosobee reduced the expression of inducible nitric oxide synthase in islets.

Takeaway

Giving special diets to mice can stop them from getting diabetes caused by a certain drug.

Methodology

NOD mice were divided into five groups and given different diets, with some receiving cyclophosphamide to induce diabetes, while others received nicotinamide or Prosobee.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Female NOD mice were used in the study.

Statistical Information

P-Value

0.03

Statistical Significance

p=0.03

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication